Intrinsiqq
Forte Biosciences, Inc. logo

Forte Biosciences, Inc.

FBRX

Compare
⚠ Showing the latest available close (Aug 28, 2026, 86 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$1.63B
EPS-$4.59
P/E-16.77
P/FCF-22.69
EV/EBITDA-15.96
FCF Yield–
Div. Yield–
Net Debt/FCF2.8x
Forte Biosciences, Inc. intrinsic value
52-Week Range
$15.67$76.99

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$88M

▼ -95.5% YoY

Op. Margin

–

ROIC

-76.66%

▼ -32.5pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$72M

▼ -65.7% YoY

Op. Cash Flow (TTM)

-$72M

▼ -65.5% YoY

Net Debt

-$198M

Net Cash Position

Cash & Equiv.

$198M

3Y CAGR: -9.8%

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with FBRX

CompareIntrinsic value
LQDALiquidia Corporation
$54.43-3.88%63
BOLTBolt Biotherapeutics Inc.
$4.91-2.96%15
TBPHTheravance Biopharma Inc.
No recent price82
TXMDTherapeuticsMD, Inc.
$1.71-5.52%29
UPBUpstream Bio, Inc.
$1.59-20.50%21
ATAIAtaiBeckley Inc.
$0.53-25.36%40
STTKShattuck Labs Inc.
$4.46-1.98%25
IMNMImmunome Inc.
$15.68-5.60%10

Held by ETFs

FBRX is in 4 US ETFs. The largest of them, with FBRX's weight in each:

Forte Biosciences (FBRX) in three numbers

Quality score
25/100
Best check: margin trend, +53384.6pp. Weakest: return on capital, -76.7%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-16.77
Negative: a loss over the last twelve months. Price to free cash flow -22.69.
Financials

Questions about Forte Biosciences

Is Forte Biosciences a high-quality business?

Forte Biosciences scores 25 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is margin trend at +53384.6pp, and its weakest is return on capital at -76.7%. The Quality tab shows every check against its target.

Does Forte Biosciences (FBRX) pay a dividend?

No. Forte Biosciences (FBRX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 7 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 28 Aug 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in FBRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing FBRX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.